Top Story

Top Takeaways from ASCO: Urothelial Cancer

Top Takeaways from ASCO: Urothelial Cancer
July 1, 2015

CHICAGO — Data on two immune checkpoint inhibitors for the treatment of urothelial cancer represent important findings for this type of cancer presented at the ASCO 2015 Annual Meeting, according to physicians who discussed the Top Takeaways from the conference with Healio.com.

Association News

Urological society presents Distinguished Service Award

June 20, 2015
The Chicago Urological Society presented its Distinguished Service Award to Robert Flanigan, MD, chair of the department of urology at Loyola University Chicago Stritch…
Meeting News Coverage

Pembrolizumab shows promise for advanced bladder cancer

June 19, 2015
CHICAGO — Pembrolizumab demonstrated encouraging antitumor activity and OS rates in patients with advanced urothelial cancer, according to study results presented…
Rini Brian In the Journals

Gene assay predicts recurrence following nephrectomy in renal cell carcinoma

June 18, 2015
Recurrence scores based on a 16-gene assay accurately predicted clinical outcomes in patients with surgically treated clear cell renal cell carcinoma, according to study…
CME
Hematology Oncology Case Consults

The Patient with Melanoma

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with melanoma.
More »
Meeting News Coverage Video
Recurrent themes of ASCO: Money and molecules

Recurrent themes of ASCO: Money and molecules

June 7, 2013
CHICAGO — Donald L. Trump, MD, FACP, president and CEO of Roswell Park Cancer Institute, offers his insights on…
More »
CME
Hematology Oncology Case Consults

Diagnosis and Management of Hemophilia

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of the patient with hemophilia supplemented with a case…
More »
Petros Grivas, MD, PhD Meeting News Coverage

Top Takeaways from ASCO: Urothelial Cancer

July 1, 2015
CHICAGO — Data on two immune checkpoint inhibitors for the treatment of urothelial cancer represent important findings for this type of cancer…
Association News

Urological society presents Distinguished Service Award

June 20, 2015
The Chicago Urological Society presented its Distinguished Service Award to Robert Flanigan, MD, chair of the department of urology at Loyola…
Meeting News Coverage

Pembrolizumab shows promise for advanced bladder cancer

June 19, 2015
CHICAGO — Pembrolizumab demonstrated encouraging antitumor activity and OS rates in patients with advanced urothelial cancer, according to…
Rini Brian In the Journals

Gene assay predicts recurrence following nephrectomy in renal cell carcinoma

June 18, 2015
Recurrence scores based on a 16-gene assay accurately predicted clinical outcomes in patients with surgically treated clear cell renal cell…
In the Journals

Death rates remain high among cancers caused by cigarette smoking

June 15, 2015
Despite significantly decreasing rates of smoking over the past 50 years, cigarette smoking continues to be the cause of death for various types of…
Andrew J. Armstrong, MD, ScM, FACP In the JournalsPerspective

Sunitinib benefits some patients with non-clear cell renal cell carcinoma

June 10, 2015
CHICAGO — Sunitinib improved radiographic PFS compared with everolimus among certain subgroups of patients with metastatic non–clear cell…
Institution Notes

AACR recognizes several researchers

HemOnc Today, June 10, 2015
Several clinicians and researchers were recognized during the American Association for Cancer Research Annual Meeting, held April 18-22 in…
Andrew M. Davidoff, MD In the Journals

Radical nephrectomy confers low risk for renal dysfunction in Wilms' tumor survivors

June 4, 2015
Patients with nonsyndromic unilateral Wilms’ tumor who underwent a unilateral radical nephrectomy without additional nephrotoxic chemotherapy…
Peter E. Clark, MD In the Journals

Statin use during surgery improves survival in renal cell carcinoma

June 4, 2015
Statin use at the time of surgery was independently associated with improved disease-specific survival and OS rates in patients with renal cell…
Meeting News CoveragePerspective

Apatorsen plus chemotherapy combination may provide survival benefit for bladder cancer

June 2, 2015
CHICAGO — The addition of apatorsen to first-line gemcitabine and cisplatin may benefit patients with advanced bladder cancer, according to…
More Headlines »
morganatic-roan